Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5189265 | 0.76 | CHAT (0.34) | RELAMAPTRAB9A | |
| SCHEMBL4413863 | 0.71 | PDGFRB (0.33) | RELAPDGFRBPDGFRAKDM4ERAB9A | |
| SCHEMBL17599277 | 0.71 | CA1 (0.38) | MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4438933 | 0.70 | MAOB (0.39) | RELA | |
| SCHEMBL6837817 | 0.68 | CHAT (0.35) | RELAMAPT | |
| Hydrochloric Acid SCHEMBL12003783 | 0.68 | MAOB (0.38) | RELA | |
| SCHEMBL28697334 | 0.68 | CHAT (0.35) | RELA | |
| SCHEMBL31506486 | 0.68 | CHAT (0.35) | RELAMAPT | |
| SCHEMBL4595773 | 0.68 | CHAT (0.39) | RELAKDM4EMAPTRAB9AALDH1A1 | |
| SCHEMBL28484538 | 0.68 | CHAT (0.39) | RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20180083191-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | CYP1A1, CYP1A2, XPOT | RELA 690/4885PDGFRB 4654/4885PDGFRA 4368/4885 |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | KCNN4, OR10J3, KCNN2 | RELA 3093/4885PDGFRB 3832/4885PDGFRA 3194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.